Methods to identify and optimize small molecules interacting with RNA (SMIRNAS)

•Non-coding RNAs are novel therapeutic targets.•Robust methodologies provide lead molecules that bind disease-causing RNAs.•Small molecules engage defined RNA motifs in cells.•New modalities emerge to modulate disease-causing RNAs more efficiently.